Joseph Shulman Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

RYTM Quotes by TradingView

Joseph Shulman is Chief Technical Officer of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 8,509 shares of RYTM, which is worth approximately $859,323. The most recent transaction as insider was on Mar 19, 2024, when has been sold 15,515 shares (Common Stock) at a price of $39.22 per share, resulting in proceeds of $608,498. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.51K
0% 3M change
28263.33% 12M change
Total Value Held $859,323

Joseph Shulman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2024
SELL
Open market or private sale
$608,498 $39.22 p/Share
15,515 Reduced 45.93%
18,265 Common Stock
Feb 16 2024
BUY
Grant, award, or other acquisition
-
33,750 Added 49.98%
33,780 Common Stock
Feb 14 2024
SELL
Open market or private sale
$54,460 $50.01 p/Share
1,089 Reduced 97.32%
30 Common Stock
Feb 13 2024
SELL
Open market or private sale
$93,250 $50.0 p/Share
1,865 Reduced 62.5%
1,119 Common Stock
Feb 13 2024
SELL
Open market or private sale
$23,574 $49.84 p/Share
473 Reduced 13.68%
2,984 Common Stock
Feb 12 2024
SELL
Open market or private sale
$40,641 $51.38 p/Share
791 Reduced 18.62%
3,457 Common Stock
Feb 11 2024
BUY
Exercise of conversion of derivative security
-
1,562 Added 26.88%
4,248 Common Stock
Feb 09 2024
SELL
Open market or private sale
$3,603,054 $50.2 p/Share
71,774 Reduced 96.39%
2,686 Common Stock
Feb 09 2024
BUY
Exercise of conversion of derivative security
$1,536,067 $21.38 p/Share
71,846 Added 49.11%
74,460 Common Stock
Feb 01 2024
SELL
Open market or private sale
$59,659 $45.06 p/Share
1,324 Reduced 33.62%
2,614 Common Stock
Feb 01 2024
BUY
Exercise of conversion of derivative security
-
3,938 Added 50.0%
3,938 Common Stock
Dec 28 2023
SELL
Open market or private sale
$396,300 $50.0 p/Share
7,926 Reduced 100.0%
0 Common Stock
Dec 28 2023
BUY
Exercise of conversion of derivative security
$145,384 $21.38 p/Share
6,800 Added 46.18%
7,926 Common Stock
Dec 27 2023
SELL
Open market or private sale
$250,800 $50.01 p/Share
5,015 Reduced 81.66%
1,126 Common Stock
Dec 27 2023
BUY
Exercise of conversion of derivative security
$51,312 $21.38 p/Share
2,400 Added 28.1%
6,141 Common Stock
Nov 14 2023
SELL
Open market or private sale
$894,432 $32.07 p/Share
27,890 Reduced 88.17%
3,741 Common Stock
Nov 14 2023
BUY
Exercise of conversion of derivative security
$189,652 $6.8 p/Share
27,890 Added 46.86%
31,631 Common Stock
Feb 14 2023
SELL
Open market or private sale
$14,885 $26.87 p/Share
554 Reduced 12.9%
3,741 Common Stock
Feb 11 2023
BUY
Exercise of conversion of derivative security
-
1,563 Added 26.68%
4,295 Common Stock
Feb 09 2023
SELL
Open market or private sale
$25,474 $27.66 p/Share
921 Reduced 25.14%
2,742 Common Stock
Feb 09 2023
BUY
Exercise of conversion of derivative security
-
2,657 Added 42.04%
3,663 Common Stock
Feb 15 2022
SELL
Open market or private sale
$3,398 $6.1 p/Share
557 Reduced 35.64%
1,006 Common Stock
Feb 11 2022
BUY
Exercise of conversion of derivative security
-
1,563 Added 50.0%
1,563 Common Stock
JS

Joseph Shulman

Chief Technical Officer
Boston, MA

Track Institutional and Insider Activities on RYTM

Follow RHYTHM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RYTM